Atlas Trials

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

Clinical trial NCT01827722 · UNKNOWN

Trial details

NCT number
NCT01827722
Sponsor
Valley Retina Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Macular EdemaCentral Retinal Vein Occlusion
Start date
2013-05-01
Primary completion
2016-05-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.